Prediction of steady-state nortriptyline plasma levels by the repeated one-point method

Area of Science:

• Pharmacology
• Psychiatry
• Clinical Chemistry

Background:

• Nortriptyline is a common antidepressant requiring therapeutic drug monitoring.
• Achieving optimal nortriptyline plasma concentrations is crucial for efficacy and safety.
• Predicting steady-state concentrations efficiently can improve patient outcomes.

Purpose of the Study:

• To evaluate the repeated one-point method for predicting nortriptyline steady-state plasma concentrations.
• To assess the accuracy of this predictive method in psychiatric inpatients with depression.

Main Methods:

• A prospective study involving 10 psychiatric inpatients diagnosed with depression.
• Collecting single plasma concentrations after the first and second daily doses of nortriptyline.
• Comparing predicted steady-state minimum plasma concentrations with measured values.

Main Results:

• The repeated one-point method demonstrated accuracy in predicting nortriptyline steady-state minimum plasma concentrations.
• The correlation coefficient between predicted and measured concentrations was high (0.946).
• The method showed a mean difference of 10.5 µg/L between predicted and measured values.

Conclusions:

• The repeated one-point method is a reliable tool for predicting nortriptyline steady-state concentrations.
• This method facilitates individualized dose adjustments, reducing time to therapeutic levels.
• It aids in achieving non-toxic nortriptyline plasma concentrations efficiently.